Jul 9, 2024
Courvoisier’s Law- Cholangiocarcinoma
Cholangiocarcinoma is a cancer originating in the rest of the biliary tract. Males are at more risk than females. It is a disease of the elderly - the 6th or 7th Decade of life. The second most common primary liver tumour. It is 3% of all Gastrointestinal cancers.
IntraHepatic Type Of Cholangiocarcinoma Extrahepatic Type Of Cholangiocarcinoma pCCA
Common Hepatic/Bile Duct PROPER iCCAOriginating from Common Bile Duct
Then Courvoisier’s Law states, "If the patient has painless jaundice and a distended, palpable gall bladder, it can not be because of gallstones.”
Intrahepatic Cholangiocarcinoma | ||
Mutation | Percentage | Drug Used |
BAP 1 | 15-25% | Vorinostat, Panobinostat |
FGFR “ fusions | 10-20% | Ponatinib, FGFR antibodies |
Extrahepatic Cholangiocarcinoma | ||
Mutation | Percentage | Drug Used |
Her2/neu | 11-22% | Trastuzumab, Pertuzumab, Lapatinib |
Ans. Klatskin Tumour
Ans. ERCP + biopsy (FNAC or brush cytology)
Ans. Surgical resection + liver transplant +/- chemotherapy or Radiology
Also Read: Achalasia Cardia- Clinical Features, Diagnosis And Treatment
Hope you found this blog helpful for your NEET SS Gastroenterology and Hepatobiliary preparation. For more informative and interesting posts like these, keep reading PrepLadder’s blogs.
Dr. Jaschandrika Rana is a dedicated Medical Academic Content Writer with over 5 years of experience. She creates insightful and motivating content for medical aspirants preparing for the FMG Exam, Medical PG Exam, Residency courses, and the NEET SS Exam. Dr. Rana’s work inspires future medical professionals to achieve top ranks and excel in their careers.
The most popular search terms used by aspirants
Avail 24-Hr Free Trial